Medication info
Expalin Tablet

Expalin Tablet

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›325mg / 1 tabletTramadol Hydrochloride›37.5mg / 1 tablet
Manufacturer / importer
Handok Co., Ltd.
Appearance
Pale yellow oblong film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200706110 · Notified 2007.05.29 · Insurance code 652105070

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Elderly Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when tramadol was administered orally to elderly patients aged 75 years and older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this medicine after dialysis to maintain analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.
Child dose
Children 12 years and older: The recommended initial dose is 2 tablets. Thereafter, allow an interval of at least 6 hours between doses and do not exceed 8 tablets per day. Children 12 years and older: Administer the lowest effective dose for the shortest possible duration. Children 12 years and older: Do not administer this medicine for longer than necessary. If long-term administration is required because of the nature and severity of the disease, perform regular monitoring to determine whether treatment with this medicine should continue.

Ingredients

Manufacturer
Handok Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute and chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Elderly Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when tramadol was administered orally to elderly patients aged 75 years and older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this medicine after dialysis to maintain analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.

Child dose

Children 12 years and older: The recommended initial dose is 2 tablets. Thereafter, allow an interval of at least 6 hours between doses and do not exceed 8 tablets per day. Children 12 years and older: Administer the lowest effective dose for the shortest possible duration. Children 12 years and older: Do not administer this medicine for longer than necessary. If long-term administration is required because of the nature and severity of the disease, perform regular monitoring to determine whether treatment with this medicine should continue.

Precautions

This medication may cause liver damage if taken by individuals who regularly consume more than three glasses of alcohol a day; therefore, consultation with a healthcare provider or pharmacist is essential. If allergic symptoms such as rash or itching occur during the use of this medication, you should discontinue use immediately and consult a healthcare professional. Tramadol, the main ingredient in this medication, can cause seizures; therefore, caution should be exercised in patients with a history of seizures or those at risk of seizures. In patients with severe asthma, use of this medication may cause severe respiratory suppression, so it should only be administered under medical supervision. Taking this medication with alcohol or central nervous system depressants such as benzodiazepines can lead to severe drowsiness, respiratory suppression, or coma, and should be avoided. Patients with elevated intracranial pressure or head injuries should exercise caution when taking this medication, as it may worsen symptoms due to respiratory suppression and increased brain pressure. Tramadol can be addictive, so long-term use should be monitored closely for signs of dependency. Patients with impaired liver function are at risk of liver damage, so they should consult a healthcare provider before use. Patients who metabolize this medication rapidly may experience excessive effects, leading to increased risk of respiratory suppression, thus requiring dose adjustments and monitoring. This medication should not be administered to children under 12 years of age or to specific post-operative pediatric patients, and use should be avoided for adolescents aged 12 to 18 if there are risk factors. This medication may induce obstructive sleep apnea and hypoxia, so symptoms should be regularly checked, and dosage should be adjusted or discontinued if symptoms worsen. Patients at risk of hyponatremia, especially the elderly or those taking related medications, should have their sodium levels monitored periodically. Individuals allergic to any component of this medication, those in severe respiratory depression states, patients with central nervous system drug toxicity, or those with severe liver, kidney, or heart disorders should not be administered this medication. Pregnant or breastfeeding women must consult with a healthcare professional before taking this medication, especially since it can be transmitted to the infant through breast milk and may pose risks. Caution should be exercised when driving or operating machinery as drowsiness or dizziness may occur due to taking this medication. In case of overdose, serious side effects such as respiratory suppression, seizures, or liver damage may occur; therefore, prescribed doses should be strictly followed, and immediate medical attention is required if overdose is suspected. This medication should be stored in a safe place out of the reach of children, and care should be taken to prevent misuse.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reaction, respiratory depression, deep sedation, coma, death, respiratory suppression, decreased appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, nervousness, emotional instability, euphoria, decreased libido, sleep disturbance, confusion, disorientation, agitation, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, hypersomnolence, sensory deficiency, tremor, paresthesia, attention deficit, syncope, memory impairment, psychomotor agitation, sedation, amnesia, perceptual disturbances, convulsions, visual impairment, visual disturbances, miosis, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, elevated liver enzymes, generalized pruritus, cold sweat, urinary disorders, erectile dysfunction, asthenia, chest pain, emotional abnormality, chills, chest discomfort, lethargy, withdrawal syndrome, thirst, irritability, warmth sensation, weight loss, increased blood creatinine, anaphylactic response, impact on unstable emotions, delirium, suicidal thoughts, muscle rigidity, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbance, prolonged prothrombin time, thrombocytopenia, agranulocytosis, blood disorders, hypoprothrombinemia, lactic acidosis, hyponatremia, fixed rash, asthenia, fever, edema, rigidity, syncope, congestive heart failure, vertigo, stupor, exacerbation of migraine, involuntary muscle contraction, dyspnea, asthma, exercise-induced dyspnea, cough, bronchitis, urinary retention, polyuria, abnormal renal function levels, oliguria, increased sweating, dysphagia, tongue swelling, increased saliva, progression of rectal cancer, progression of esophageal cancer, progression of stomach cancer, paralytic ileus, hiccups, cholecystitis, sedation, insomnia, decreased appetite, anxiety, depression, nervousness, emotional instability, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, palpitations, arrhythmia, exacerbation of hypertension, aortic stenosis, gastrointestinal bleeding, increased cholesterol, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, epistaxis, abnormal vision, progression of biliary cancer, foreign body sensation in the eye, progression of liver cancer, liver dysfunction, nausea, vertigo, stupor, dyspnea, confusion, multiple organ failure, intentional overdose, belching, chest discomfort, anxiety, sweating, rigidity, pain, diarrhea, upper respiratory syndrome, lip tremor, agitation, hyperactivity, withdrawal symptoms, urticaria, bronchospasm, toxic skin necrosis, allergic reaction, panic attacks, severe anxiety, hallucinations, perceptual disturbances, tinnitus, abnormal central nervous system response, seizures, serotonin syndrome, toxic skin necrosis, opioid-induced hyperalgesia, acute or chronic adrenal insufficiency, severe abdominal pain, hypotension, extreme fatigue, decreased appetite, weight loss, respiratory arrest, QT prolongation, renal tubular necrosis, coagulation disorders, abdominal discomfort, lethargy, pallor, hyperhidrosis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture intrusion, away from direct sunlight, and at room temperature, preferably below 25 degrees Celsius.

Appearance and packaging

Appearance

Pale yellow oblong film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.